Inguanzo, Anna http://orcid.org/0000-0003-0879-5875
Poulakis, Konstantinos http://orcid.org/0000-0002-6600-8086
Mohanty, Rosaleena
Schwarz, Christopher G. http://orcid.org/0000-0002-1466-8357
Przybelski, Scott A.
Diaz-Galvan, Patricia http://orcid.org/0000-0001-6155-5585
Lowe, Val J.
Boeve, Bradley F. http://orcid.org/0000-0002-4153-8187
Lemstra, Afina W.
van de Beek, Marleen
van der Flier, Wiesje
Barkhof, Frederik
Blanc, Frederic
Loureiro de Sousa, Paulo
Philippi, Nathalie http://orcid.org/0000-0002-6483-9222
Cretin, Benjamin
Demuynck, Catherine
Nedelska, Zuzana http://orcid.org/0000-0002-3269-2115
Hort, Jakub
Segura, Barbara http://orcid.org/0000-0002-9673-5479
Junque, Carme
Oppedal, Ketil
Aarsland, Dag http://orcid.org/0000-0001-6314-216X
Westman, Eric http://orcid.org/0000-0002-3115-2977
Kantarci, Kejal
Ferreira, Daniel http://orcid.org/0000-0001-9522-4338
Article History
Received: 30 August 2022
Accepted: 5 January 2023
First Online: 20 January 2023
Competing interests
: A I., K.P., R.M., C.G.S., S.A.P., P.D-G., A.W.L., M.B., W.F., P. L.S., N.P., B.C., C.D., Z.N., J.H., B.S., C.J., K.O., E.W. and D.F. report no disclosures relevant to the manuscript. V.J.L. consults for Bayer Schering Pharma, Piramal Life Sciences, Life Molecular Imaging, Eisai Inc., AVID Radiopharmaceuticals, and Merck Research and receives research support from GE Healthcare, Siemens Molecular Imaging, AVID Radiopharmaceuticals and the NIH (NIA, NCI). B.F.B. has served as an investigator for clinical trials sponsored by Biogen and Alector. He receives royalties from the publication of a book entitled Behavioral Neurology of Dementia (Cambridge Medicine, 2017), serves on the Scientific Advisory Board of the Tau Consortium, and receives research support from NIH, the Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program, the Little Family Foundation, and the Ted Turner and Family Foundation LBD Functional Genomics Program. F.Ba. is supported by the NIHR biomedical research centre at UCLH. F.Bl. has served as national coordinator and principal investigator for clinical trials sponsored by Biogen, Roche, Axovant and Eisai. D.A. has received research support and/or honoraria from AstraZeneca, H. Lundbeck, Novartis Pharmaceuticals and GE Health, and served as paid consultant for H. Lundbeck, Eisai and Evonik. K. K. serves on the data safety monitoring board for Takeda Global Research and Development Center, Inc.; receives research support from Avid Radiopharmaceuticals and Eli Lilly, and receives funding from NIH and Alzheimer’s Drug Discovery Foundation. All authors declare no competing interests.